Atrás
Rango del Día
$8.74
$9.08
Rango de 52 Semanas
$5.81
$9.98
Volumen
554,048
Promedio 50D / 200D
$8.36
/
$7.36
Cierre Anterior
$8.64
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 26.7 | 0.4 |
| P/B | 3.3 | 2.9 |
| ROE % | 13.7 | 3.7 |
| Net Margin % | 4.0 | 3.8 |
| Rev Growth 5Y % | 7.2 | 10.0 |
| D/E | 1.7 | 0.2 |
Puntos Clave
Revenue grew 7.15% annually over 5 years — modest growth
ROE of 13.69% — decent returns on equity
Generating 71.41M in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 8.06%
Cash machine — converts 314.16% of earnings into free cash flow
Capital efficient — spends only 0.45% of revenue on capex
Crecimiento
Revenue Growth (5Y)
7.15%
Revenue (1Y)-0.91%
Earnings (1Y)N/A
FCF Growth (3Y)199.11%
Calidad
Return on Equity
13.69%
ROIC8.86%
Net Margin4.00%
Op. Margin10.31%
Seguridad
Debt / Equity
1.69
Current Ratio1.70
Interest Coverage2.21
Valoración
P/E Ratio
26.67
P/B Ratio3.29
EV/EBITDA14.80
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -0.91% | Revenue Growth (3Y) | 5.30% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 7.15% | Earnings Growth (5Y) | 4.08% |
| Profitability | |||
| Revenue (TTM) | 568.09M | Net Income (TTM) | 22.73M |
| ROE | 13.69% | ROA | 3.33% |
| Gross Margin | 67.32% | Operating Margin | 10.31% |
| Net Margin | 4.00% | Free Cash Flow (TTM) | 71.41M |
| ROIC | 8.86% | FCF Growth (3Y) | 199.11% |
| Safety | |||
| Debt / Equity | 1.69 | Current Ratio | 1.70 |
| Interest Coverage | 2.21 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 26.67 | P/B Ratio | 3.29 |
| P/S Ratio | 1.07 | PEG Ratio | -0.13 |
| EV/EBITDA | 14.80 | Dividend Yield | 0.00% |
| Market Cap | 606.31M | Enterprise Value | 866.42M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 568.09M | 573.28M | 512.35M | 512.12M | 430.90M |
| Net Income | 22.73M | -33.54M | -156.23M | -158.70M | 19.38M |
| EPS (Diluted) | 0.33 | -0.52 | -2.49 | -2.59 | -0.15 |
| Gross Profit | 382.43M | 388.23M | 328.19M | 331.08M | 302.71M |
| Operating Income | 58.55M | -11.98M | -81.73M | -167.23M | 12.06M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 683.56M | 727.96M | 810.91M | 1.37B | 1.23B |
| Total Liabilities | 455.11M | 542.35M | 589.79M | 960.43M | 692.07M |
| Shareholders' Equity | 184.11M | 147.94M | 173.59M | 325.24M | 458.92M |
| Total Debt | 311.35M | 335.63M | 394.85M | 418.07M | 357.68M |
| Cash & Equivalents | 51.24M | 41.58M | 36.96M | 30.19M | 43.93M |
| Current Assets | 272.84M | 275.61M | 268.00M | 272.58M | 263.10M |
| Current Liabilities | 160.38M | 210.40M | 175.50M | 304.02M | 180.86M |